RU2160735C2 - Бензопираны, способ их получения, промежуточные соединения и фармацевтические композиции - Google Patents

Бензопираны, способ их получения, промежуточные соединения и фармацевтические композиции Download PDF

Info

Publication number
RU2160735C2
RU2160735C2 RU97120993/04A RU97120993A RU2160735C2 RU 2160735 C2 RU2160735 C2 RU 2160735C2 RU 97120993/04 A RU97120993/04 A RU 97120993/04A RU 97120993 A RU97120993 A RU 97120993A RU 2160735 C2 RU2160735 C2 RU 2160735C2
Authority
RU
Russia
Prior art keywords
benzopyran
dihydro
dimethyl
trans
hydroxy
Prior art date
Application number
RU97120993/04A
Other languages
English (en)
Russian (ru)
Other versions
RU97120993A (ru
Inventor
Пол У. Мэнли
Original Assignee
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10774940&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2160735(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Новартис Аг filed Critical Новартис Аг
Publication of RU97120993A publication Critical patent/RU97120993A/ru
Application granted granted Critical
Publication of RU2160735C2 publication Critical patent/RU2160735C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU97120993/04A 1995-05-24 1996-05-24 Бензопираны, способ их получения, промежуточные соединения и фармацевтические композиции RU2160735C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9510477.4A GB9510477D0 (en) 1995-05-24 1995-05-24 Organic compounds
GB9510477.4 1995-05-24

Publications (2)

Publication Number Publication Date
RU97120993A RU97120993A (ru) 1999-11-10
RU2160735C2 true RU2160735C2 (ru) 2000-12-20

Family

ID=10774940

Family Applications (1)

Application Number Title Priority Date Filing Date
RU97120993/04A RU2160735C2 (ru) 1995-05-24 1996-05-24 Бензопираны, способ их получения, промежуточные соединения и фармацевтические композиции

Country Status (30)

Country Link
US (1) US5905156A (enExample)
EP (1) EP0828733B1 (enExample)
JP (1) JPH11505820A (enExample)
KR (1) KR100437981B1 (enExample)
CN (1) CN1077888C (enExample)
AR (1) AR004489A1 (enExample)
AT (1) ATE205204T1 (enExample)
AU (1) AU703276B2 (enExample)
BR (1) BR9609048A (enExample)
CA (1) CA2217821C (enExample)
CO (1) CO4700520A1 (enExample)
CZ (1) CZ294474B6 (enExample)
DE (1) DE69615019T2 (enExample)
DK (1) DK0828733T3 (enExample)
ES (1) ES2163634T3 (enExample)
FI (1) FI973992L (enExample)
GB (1) GB9510477D0 (enExample)
HU (1) HU222772B1 (enExample)
IL (1) IL118382A (enExample)
MY (1) MY114924A (enExample)
NO (1) NO314846B1 (enExample)
NZ (1) NZ309765A (enExample)
PL (1) PL184144B1 (enExample)
PT (1) PT828733E (enExample)
RU (1) RU2160735C2 (enExample)
SK (1) SK283215B6 (enExample)
TR (1) TR199701417T1 (enExample)
TW (1) TW421646B (enExample)
WO (1) WO1996037490A1 (enExample)
ZA (1) ZA964209B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2314302C2 (ru) * 2002-08-29 2008-01-10 Ниссан Кемикал Индастриз, ЛТД Способ получения производного аминобензопирана

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972894A (en) * 1997-08-07 1999-10-26 Cytran, Inc. Peptides having potassium channel opener activity
GB9822024D0 (en) * 1998-10-09 1998-12-02 Novartis Ag Organic compounds
GB9909792D0 (en) 1998-12-04 1999-06-23 Cambridge Bioclinical Limited Potassium channel activators and their use
US6384244B2 (en) 2000-05-18 2002-05-07 Merck & Co., Inc. Process for preparing cis- aminochromanols
US7098340B2 (en) * 2003-05-14 2006-08-29 Warner Lambert Company Llc Benzyl sulfonamide derivatives
KR100704009B1 (ko) * 2005-08-30 2007-04-04 한국화학연구원 염증억제 활성을 가지는6-알킬아미노-2-메틸-2'-(ｎ-메틸치환술폰아미도)메틸-2ｈ-1-벤조피란 유도체
BR112018006189A2 (pt) 2015-09-28 2018-10-09 Genentech Inc compostos da fórmula, composição farmacêutica, métodos de tratamento de uma doença, de diminuição do fluxo de íons e de tratamento de prurido em um mamífero, método para tratamento de dores em um mamífero e uso de um composto
CN106008288A (zh) * 2016-06-15 2016-10-12 西北农林科技大学 一种苯磺酰胺类化合物及其用途
JP2020511511A (ja) * 2017-03-24 2020-04-16 ジェネンテック， インコーポレイテッド ナトリウムチャネル阻害剤としての４−ピペリジン−ｎ−（ピリミジン−４−イル）クロマン−７−スルホンアミド誘導体
TW202003490A (zh) 2018-05-22 2020-01-16 瑞士商赫孚孟拉羅股份公司 治療性化合物及其使用方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1757466A3 (ru) * 1987-07-06 1992-08-23 Ф.Хоффманн - Ля Рош Аг (Фирма) Способ получени производных бензопирана или их фармацевтически приемлемых аддитивных солей
US5236936A (en) * 1991-02-11 1993-08-17 Imperial Chemical Industries Plc Pyridine compounds which are useful as angiotensin ii receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2030627A6 (es) * 1990-11-28 1992-11-01 Uriach & Cia Sa J Procedimiento para la obtencion de compuestos benzopiranicos.
KR950009863B1 (ko) * 1991-05-22 1995-08-29 재단법인한국화학연구소 벤조피란 유도체와 그의 제조방법
TW244350B (enExample) * 1991-12-14 1995-04-01 Hoechst Ag
US5236935A (en) * 1992-05-21 1993-08-17 Korea Research Institute Of Chemical Technology Benzopyran derivatives and processes for the preparation thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1757466A3 (ru) * 1987-07-06 1992-08-23 Ф.Хоффманн - Ля Рош Аг (Фирма) Способ получени производных бензопирана или их фармацевтически приемлемых аддитивных солей
US5236936A (en) * 1991-02-11 1993-08-17 Imperial Chemical Industries Plc Pyridine compounds which are useful as angiotensin ii receptor antagonists

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2314302C2 (ru) * 2002-08-29 2008-01-10 Ниссан Кемикал Индастриз, ЛТД Способ получения производного аминобензопирана

Also Published As

Publication number Publication date
EP0828733B1 (en) 2001-09-05
CA2217821A1 (en) 1996-11-28
JPH11505820A (ja) 1999-05-25
NO975365D0 (no) 1997-11-21
HU222772B1 (hu) 2003-10-28
CO4700520A1 (es) 1998-12-29
AU703276B2 (en) 1999-03-25
NO314846B1 (no) 2003-06-02
EP0828733A1 (en) 1998-03-18
TW421646B (en) 2001-02-11
SK157797A3 (en) 1998-05-06
KR19990021925A (ko) 1999-03-25
BR9609048A (pt) 1999-02-23
CN1185153A (zh) 1998-06-17
MY114924A (en) 2003-02-28
FI973992A0 (fi) 1997-10-17
CA2217821C (en) 2008-05-06
AU6000896A (en) 1996-12-11
TR199701417T1 (xx) 1998-02-21
CN1077888C (zh) 2002-01-16
HK1014137A1 (en) 1999-09-24
FI973992A7 (fi) 1997-12-09
CZ294474B6 (cs) 2005-01-12
GB9510477D0 (en) 1995-07-19
WO1996037490A1 (en) 1996-11-28
CZ368897A3 (cs) 1998-02-18
SK283215B6 (sk) 2003-03-04
ES2163634T3 (es) 2002-02-01
NZ309765A (en) 2000-01-28
IL118382A (en) 2000-01-31
HUP9801751A2 (hu) 1999-06-28
NO975365L (no) 1998-01-15
KR100437981B1 (ko) 2004-07-16
ZA964209B (en) 1997-11-24
DK0828733T3 (da) 2001-12-17
DE69615019D1 (de) 2001-10-11
MX9709004A (es) 1998-03-31
DE69615019T2 (de) 2002-06-06
IL118382A0 (en) 1996-09-12
PL184144B1 (pl) 2002-09-30
US5905156A (en) 1999-05-18
HUP9801751A3 (en) 1999-08-30
AR004489A1 (es) 1998-12-16
FI973992L (fi) 1997-12-09
PL324042A1 (en) 1998-05-11
ATE205204T1 (de) 2001-09-15
PT828733E (pt) 2002-02-28

Similar Documents

Publication Publication Date Title
RU2160735C2 (ru) Бензопираны, способ их получения, промежуточные соединения и фармацевтические композиции
FI110940B (fi) Menetelmä terapeuttisesti aktiivisten kinoloni- ja akridonijohdannaisten valmistamiseksi
JP2001512103A (ja) 第ｘａ因子を阻害する複素環誘導体
US5212182A (en) Substituted quinolinyl- and naphthalenylbenzamides or benzylamines and related compounds useful as analgesics
JP2001511799A (ja) オキシド−スクアレンシクラーゼ阻害剤として有用なヘテロ環式化合物
US5574049A (en) 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrans
WO1994012493A1 (en) 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2h-1-benzopyr ans, their use as pharmaceuticals
RU2104277C1 (ru) 2-2-диалкил- или транс-2,2-диалкил-3,4-дигидро-3-гидрокси-6-(пиридин-4-ил)-2н-1-бензопиран
MXPA97009004A (en) Benzopira
PL182031B1 (pl) (S)-(-)-2-trifluorometylo-4-(3-cyjanofenylo)-4,6,7,8-tetrahydro-5(1H)-chinolon i jego farmaceutycznie dozwolone sole, kompozycja farmaceutyczna zawierajaca ten zwiazek oraz sposób wytwarzania tego zwiazku PL PL PL
JP2583028B2 (ja) ２，２−ジアルキル−および２，２−ジアルキル−３，４−ジヒドロ−３−ヒドロキシ−−２ｈ−１−ベンゾピラン類
CZ282091B6 (cs) 2,2-Dialkyl-2H-1-benzopyrany a 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrany
SK88994A3 (en) 2,2-dialkyl-2h-1-benzopyrans and 2,2-dialkyl-3,4-dihydro- -3-hydroxy-2h-1-benzopyrans
HU192576B (en) Process for the production of diazine-ethenil-phenyl-oxanilic acids, as well as of esters and salts thereof
NZ245321A (en) Substituted 6-(pyridin-4-yl)-2h-1-benzopyran derivatives and pharmaceutical compositions thereof
HK1014137B (en) Benzopyrans and pharmaceutical compositions containing them
PL172371B1 (pl) Sposób wytwarzania 2,2-diaikilo- i 2,2-dialkilo-3,4- dihydro-3-hydroksy-2H-1-benzopiranów PL
WO2000021957A1 (en) Benzopyrans having potassium channel opening activity
HK1013999B (en) Quinolone derivative for treatment of urinary incontinence
JPH09227563A (ja) 複素環式化合物
JPWO1996032370A1 (ja) ４−アミノ−５−オキシ−２，６，６−トリメチル−２−シクロヘプテン化合物

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20130525